Skip to main content
. 2022 Jan 17;2022:3837418. doi: 10.1155/2022/3837418

Table 3.

Severity and duration of exacerbations during the study.

Placebo Active treatment
Total number of exacerbations 67 24
Severity
 Mild 21 (31.3%) 4 (16.7%)
 Moderate 44 (65.7%) 19 (79.2%)
 Severe 2 (3.0%) 1 (4.2%)
Duration (days) 3.3 ± 2.57 3.3 ± 2.45